Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01377649 · ClinicalTrials.gov registry record
Contrast Ultrasound Perfusion Imaging in Peripheral Arterial Disease (PAD)
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 18
- Enrollment target
NCT01377649 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 18 participants.
The verdict
NCT01377649 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
Contrast ultrasound is a technique that can quantify blood flow in the tissues of the body by ultrasound detection of microbubble contrast agents that behave in the circulation similar to red blood cells. In this study, the investigators hypothesize that contrast ultrasound of blood flow in the leg (thigh and calf) at rest and during stress produced by medications that mimic exercise (vasodilator stress) can provide information on the location and severity of peripheral vascular disease (blockages of the blood vessels in the leg). The investigators will also determine whether symptom improvement after revascularization (procedures to open up or bypass the blockages) is directly related to the improvement in blood flow.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2011-07 |
| Est. Completion | 2016-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01377649
The ClinicalTrials.gov registry entry for NCT01377649 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01377649 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01377649 about?
NCT01377649 is a clinical study titled "Contrast Ultrasound Perfusion Imaging in Peripheral Arterial Disease (PAD)". Contrast ultrasound is a technique that can quantify blood flow in the tissues of the body by ultrasound detection of microbubble contrast agents that behave in the circulation similar to red blood cells. In this study, the investigators hypothesize that contrast ultrasound of blood flow in the leg ...
What is the current status of trial NCT01377649?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2011-07. Estimated completion is 2016-09.
Who is sponsoring clinical trial NCT01377649?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.